Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975

EF Smit; JPAM (Jan) van Meerbeeck; P Lianes; C Debruyne; C Legrand; F Schramel; H Smit; R Gaafar; B Biesma; C Manegold; N Neymark; G Giaccone

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975

EF Smit, JPAM (Jan) van Meerbeeck, P Lianes, C Debruyne, C Legrand, F Schramel, H Smit, R Gaafar, B Biesma, C Manegold, N Neymark, G Giaccone

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

356 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	3909-3917
Number of pages	9
Journal	Journal of Clinical Oncology
Volume	21
Publication status	Published - 2003

Research programs

EMC MM-04-42-02

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Smit, EF., van Meerbeeck, JPAM., Lianes, P., Debruyne, C., Legrand, C., Schramel, F., Smit, H., Gaafar, R., Biesma, B., Manegold, C., Neymark, N., & Giaccone, G. (2003). Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975. Journal of Clinical Oncology, 21, 3909-3917.

@article{2f3ebf7bbc5b4602a7892799a692db3d,

title = "Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975",

author = "EF Smit and {van Meerbeeck}, {JPAM (Jan)} and P Lianes and C Debruyne and C Legrand and F Schramel and H Smit and R Gaafar and B Biesma and C Manegold and N Neymark and G Giaccone",

year = "2003",

language = "Undefined/Unknown",

volume = "21",

pages = "3909--3917",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

}

Smit, EF, van Meerbeeck, JPAM, Lianes, P, Debruyne, C, Legrand, C, Schramel, F, Smit, H, Gaafar, R, Biesma, B, Manegold, C, Neymark, N & Giaccone, G 2003, 'Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975', Journal of Clinical Oncology, vol. 21, pp. 3909-3917.

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975. / Smit, EF; van Meerbeeck, JPAM (Jan); Lianes, P et al.
In: Journal of Clinical Oncology, Vol. 21, 2003, p. 3909-3917.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975

AU - Smit, EF

AU - van Meerbeeck, JPAM (Jan)

AU - Lianes, P

AU - Debruyne, C

AU - Legrand, C

AU - Schramel, F

AU - Smit, H

AU - Gaafar, R

AU - Biesma, B

AU - Manegold, C

AU - Neymark, N

AU - Giaccone, G

PY - 2003

Y1 - 2003

M3 - Article

SN - 0732-183X

VL - 21

SP - 3909

EP - 3917

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Smit EF, van Meerbeeck JPAM, Lianes P, Debruyne C, Legrand C, Schramel F et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975. Journal of Clinical Oncology. 2003;21:3909-3917.